Wint(TM) kit

Products

Information

Wint (TM) is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint(TM) separation device, due to presence of the exclusive borosilicate activator triggers the release of DKK-1 protein from the isolated and concentrated platelets (PLTs). Since Wint(TM) separation device allows to obtain a final product dedicated for intra-articular injection abundant in DKK-1 protein, subsequent therapy based on this blood derived product aims to inhibit the deleterious Wnt signaling pathway in the joint tissues.

Distribution Areas

OceaniaAfricaCentral America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)

Supplied From

Poland

All categories

Biopharmaceutical ProductsRegenerative MedicinePharmaceutical Machinery & TechnologyMedical DevicesProducts

Main Categories

Biopharmaceutical ProductsPharmaceutical Machinery & Technology

Biovico Sp. z o.o.Biovico is a biotechnology and pharmaceutical company focused on researching and developing new innovative and rigorously tested products, manufacturing in the highest GMP level quality and providing with comprehensive and holistic solutions to professionals and patients around the world. From inception in 2008 R&D was a clear focus, understanding that the most important and lasting effects can come only through scientific endeavour. Very soon the first HA product Biolevox family was developed and the line continued to grow and expand.

Wint(TM) kit

Information

Log in